心失败(HF ) 是严重的心疾病。自体同源的骨头髓干细胞(BMC ) 的使用在 HF 的治疗的动员是一个热话题在西方的药和中国药(厘米) 研究两个。为 HF 治疗的 BMC 动员的学习上有许多临床的试用和实验,包括综合的药。BMC 动员的效果为心脏的修理是有利的,当厘米的一些优点在对待 HF 的 BMC 动员支持它的申请的先进学习时。另外,与为 HF 的处理的自体同源的 BMC 动员的机制,那以后将被揭示,特别干细胞壁龛,综合的药将逐渐地在治疗模型的这个临床的想法起一个重要作用。同时,厘米应该作为保持自己的特征在 HF 处理上改编干细胞进步的新途径。
Heart failure (HF) is a severe heart disease. The use of autologous bone marrow stem cells (BMCs) mobilization in the treatment of HF has been a hot topic to research both in Western medicine and Chinese medicine (CM). There are many clinical trials and experiments on study of BMCs mobilization for HF therapy, including integrative medicine. The effect of BMCs mobilization is favorable for cardiac repair, while some advantages of CM support the advanced study of its application in BMCs mobilization to treat HF. In addition, with mechanisms of autologous BMCs mobilization for the treatment of HF that will be revealed in the future, especially stem cells niches, integrative medicine would play an important role in this clinical thought of therapy model gradually. Simultaneously, CM should adapt the new approaches of stem cells progresses on HF treatment as holding characteristics of itself.